Wisconsin Rx National CooperativeRx
The SCRxIPT - Weekly Newsletter For Members and Stakeholders

Rx News | July 13, 2012

About Us
The Co-op Difference
Members
Employers
Brokers and TPAs
Cost Savings
Adding Value
Press Room
Event Calendar
How To Join Rx

Upcoming Events featuring
National CooperativeRx
6th Annual Pharmacy Benefits Academy

July 30-August 1, 2012   

Rosemont, IL 

Learn more

Mid-Sized Retirement & Healthcare Plan Management Conference

September 9-12, 2012   

Las Vegas, NV 

Learn more

RASHRM Annual Conference

October 16, 2012   

Rockford, IL 

Learn more
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at 866-679-9479, extension 223

Coalition News

Stay Cool

 

With 2012 being the hottest year on record for the US, it's important to remind people of the dangers of hot weather.  Excessive heat can lead to cramps, dehydration, fatigue, sunburn, and/or heat stroke.

Ways to avoid the dangers of high temperatures include watching the temperature, drinking plenty of fluids, dressing appropriately, and wearing sunscreen.

For more information, visit the Mayo Clinic site devoted to Heat and exercise: keeping cool in hot weather.

 

 

News You Can Use

The New York Times.  At a time when health care costs are becoming a larger concern, a loophole in many states' workers compensation laws are allowing physicians to sell pharmaceutical drugs at a high markup.  Doctor dispensing can be convenient for patients, but a huge expense for insurance companies.  (Meier, Thomas, 7/11)   Full story    

 

The Huffington Post.  More of an opinion article, this author reviews the recent settlement of $3B paid by GlaxoSmithKline.  After making $27.5B on 3 antidepressants that were inappropriately marketed, he states the fine can "almost be considered a cost of doing business," and asks that the individuals responsible be held accountable in order to deter future industry misconduct.  (Reich, 7/6)  Full story  

 

Industry News
CBS NewsPurdue Pharma LP, the manufacturer of OxyContin, is currently studying the drug in children aged 6-16.  The children involved suffer from moderate to severe pain, and the study is meant to examine the safety of the drug for use in children.  (Castillo, 7/5)  Full Story

ABC NewsA new study involving fertility treatments and breast cancer has found that women who take fertility treatments and don't get pregnant have a slightly lower risk of developing breast cancer.  Women who have fertility treatments and do get pregnant have a slightly higher breast cancer risk.  (Gann, 7/6)  Full Story

Health Policy Matters
Beaumont Enterprises.  New legislation is anticipated to be signed into law by President Obama to encourage drug companies to create drugs for rare childhood diseases.  Incentives include faster FDA approval and longer patents.  (Powell, 7/7)  Full Story

The Wall Street Journal.  India is getting set to release their $5.4B plan to cover free pharmaceutical drugs for their citizens. This article describes the direction India is heading, and some obstacles in its way.  (Ahmed, 7/6)  Full story